---
title: "NP35925 Cardiovascular & Respiratory Medicines"
ocid: "ocds-h6vhtk-04afa6"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04afa6"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04afa6.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04afa6.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-05-06"
---

# NP35925 Cardiovascular & Respiratory Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-h6vhtk-04afa6

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04afa6)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04afa6.json)

## Summary

In the recent procurement process led by The Common Services Agency, known as NHS National Services Scotland (NSS), a contract was awarded for supplying Cardiovascular and Respiratory Medicines under the title "NP35925". The procurement falls into the pharmaceutical industry category, specifically covering goods and was conducted via an open procedure. Key dates include the award date on 7th April 2025, with a framework agreement duration spanning 36 months, extendable by an additional 24 months. Locations involved in the delivery include various regions within Scotland, ensuring broad NHS coverage under the entities established by the National Health Service (Scotland) Act and integrated joint boards. This tender involved multiple lots and aimed to contract with a maximum of six suppliers per framework agreement for each product line, focusing on both logistics and price evaluation criteria.

This tender presents significant opportunities for businesses specializing in pharmaceutical goods, particularly those offering innovative cardiovascular and respiratory medicine solutions. With a substantial estimated contract value and structured multi-supplier framework agreements, it is an excellent opportunity for large pharmaceutical companies to bolster their presence in the UK healthcare market. Companies with capabilities in logistics and competitive pricing will find this tender particularly advantageous. Additionally, the tender encourages participants to support community benefits alongside NHS Scotland’s initiatives, thus appealing to companies that focus on sustainability and community engagement strategies. By participating, businesses can leverage this contract to expand their market reach and enhance their service offerings to a critical segment of the healthcare sector in Scotland.

## Notice

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

### Lot Information

Epoprostenol Powder and Solvent (pH 10.5) for Solution for Infusion Vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinephrine (Adrenaline) Pre-Filled Syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Epinephrine (Adrenaline) Auto Injector Devices

Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Enoxaparin Sodium Injection

Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Urokinase Injections

Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Nifedipine Modified-Release (M/R) Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Theophylline Modified-Release (M/R) Capsules and Tablets

Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Dalteparin Injections

Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Tinzaparin Sodium Injections

Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Icatibant Solution for Injection

Supply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Treprostinil Injection

Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

Direct Acting Oral Anticoagulants (DOACs)

Supply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

All Other Cardiovascular & Respiratory Medicines

Supply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.

Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/019020-2025 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 6 May 2025 |
| Submission deadline | 20 Nov 2024 |
| Future notice date | Not specified |
| Award date | 6 Apr 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £95,148,458 |
| Lots value | £95,148,450 |
| Awards value | Not specified |
| Contracts value | £82,305,880 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Active, Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 42 |
| Supplier names | ACCORD; AGUETTANT; ASPIRE; AVENTIS PHARMA LTD T/A SANOFI; BOWMED IBISQUS; BRISTOL LABORATORIES; CELIX PHARMA; CHIESI; COLONIS PHARMA; CONSILIENT HEALTH; CST PHARMA; DAY LEWIS MEDICAL; DR REDDY'S LABORATORIES (UK; FOCUS PHARMACEUTICALS; GALVANY PHARMA; GENNISIUM PHARMA; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; GRINDEKS KALCEKS; HAMELN PHARMA; HIKMA PHARMACEUTICAL INTERNATIONAL; KENT PHARMACEUTICALS; MACURE PHARMA; MARTINDALE PHARMA; MERCURY PHARMACEUTICALS; MORNINGSIDE PHARMACEUTICALS; MSN LABS; NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST; PERENNIAL PHARMA; PFIZER; RANBAXY (UK; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; STADA UK - THORNTON & ROSS; STIRLING ANGLIAN PHARMACEUTICALS; SYRIMED; TECHDOW PHARMA ENGLAND; VENIPHARM; VIATRIS UK HEALTHCARE; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 6 May 2025 at 10:14 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/019020-2025
- 21 Oct 2024 at 13:00 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/033950-2024

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000777704
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
- https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04afa6. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04afa6.json.